Chao Che

Prof. Dr. Chao Che

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2009 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
CCChao Che
Chao Che
WLWenzhao Li
Wenzhao Li
SLShengyue Lin
Shengyue Lin
JCJiwei Chen
Jiwei Chen
JZJie Zheng
Jie Zheng
BJBiwang Jiang
Biwang Jiang
Magnetically recyclable Hoveyda–Grubbs catalyst can be readily assembled using magnetic nanoparticles as support, and this catalyst combines convenient recyclability and excellent activity on ring-closing metathesis (RCM) reactions.

18 August 2007 in Journal of Combinatorial Chemistry
Verified
Journal Article
Closed access
CCChao Che
Chao Che
JXJing Xiang
Jing Xiang
GWGuo-Xin Wang
Guo-Xin Wang
RFReza Fathi
Reza Fathi
JQJun-Min Quan
Jun-Min Quan
ZYZhen Yang
Zhen Yang

9 December 2008 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LLLianzhu Liu
Lianzhu Liu
YGYingxiang Gao
Yingxiang Gao
CCChao Che
Chao Che
NWNa Wu
Na Wu
DWDavid Zhigang Wang
David Zhigang Wang
ZYZhen Yang
Zhen Yang
A unified strategy towards the facile construction of the [6.7.6.5] oxapentacyclic skeleton of cortistatins is reported, featuring intramolecular Diels–Alder (IMDA) and oxidative dearomatization–cyclization reactions as key steps.

21 September 2010 in Organic Letters
Verified
Journal Article
Closed access
CCChao Che
Chao Che
SLSong Li
Song Li
XJXianlong Jiang
Xianlong Jiang
JQJunmin Quan
Junmin Quan
SLShuo Lin
Shuo Lin
ZYZhen Yang
Zhen Yang

26 February 2013 in ACS Combinatorial Science
Verified
Journal Article
Closed access
CCChao Che
Chao Che
SLSong Li
Song Li
ZYZhixiong Yu
Zhixiong Yu
FLFangfang Li
Fangfang Li
SXShengchang Xin
Shengchang Xin
ZYZhen Yang
Zhen Yang

5 February 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JXJing Xiang
Jing Xiang
HYHongbo Yang
Hongbo Yang
CCChao Che
Chao Che
HZHaixia Zou
Haixia Zou
HYHanshuo Yang
Hanshuo Yang
SLShuo Lin
Shuo Lin
Cyclin-dependent kinases (CDKs) play important roles in regulating cell cycle progression, and altered cell cycles resulting from over-expression or abnormal activation of CDKs observed in many human cancers. As a result, CDKs have become extensive studied targets for developing chemical inhibitors for cancer therapies; however, protein kinases share a highly conserved ATP binding pocket at which most chemical inhibitors bind, therefore, a major challenge in developing kinase inhibitors is achieving target selectivity. To identify cell growth inhibitors with potential applications in cancer therapy, we used an integrated approach that combines one-pot chemical synthesis in a combinatorial manner to generate diversified small molecules with new chemical scaffolds coupled with growth inhibition assay using developing zebrafish embryos. We report the successful identification of a novel lead compound that displays selective inhibitory effects on CDK2 activity, cancer cell proliferation, and tumor progression in vivo. Our approaches should have general applications in developing cell proliferation inhibitors using an efficient combinatorial chemical genetic method and integrated biological assays. The novel cell growth inhibitor we identified should have potential as a cancer therapeutic agent.